133 related articles for article (PubMed ID: 24272676)
1. NOB1 in non-small-cell lung cancer: expression profile and clinical significance.
Liu K; Gu MM; Chen HL; You QS
Pathol Oncol Res; 2014 Apr; 20(2):461-6. PubMed ID: 24272676
[TBL] [Abstract][Full Text] [Related]
2. miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1.
Liu K; Chen H; You Q; Ye Q; Wang F; Wang S; Zhang S; Yu K; Li W; Gu M
Int J Oncol; 2018 Jul; 53(1):257-265. PubMed ID: 29749434
[TBL] [Abstract][Full Text] [Related]
3. High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes.
Liu K; Chen HL; Wang S; Gu MM; Chen XM; Zhang SL; Yu KJ; You QS
Sci Rep; 2016 Jun; 6():28666. PubMed ID: 27346559
[TBL] [Abstract][Full Text] [Related]
4. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
[TBL] [Abstract][Full Text] [Related]
5. NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
J Chemother; 2016 Jun; 28(3):225-9. PubMed ID: 25971309
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
[TBL] [Abstract][Full Text] [Related]
7. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Biol Markers; 2015 Feb; 30(1):e43-8. PubMed ID: 25450647
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.
Li Y; Ma C; Qian M; Wen Z; Jing H; Qian D
Oncol Rep; 2014 Mar; 31(3):1271-6. PubMed ID: 24452698
[TBL] [Abstract][Full Text] [Related]
9. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
10. EXPRESSION MECHANISM AND CLINICAL SIGNIFICANCE OF NOB1 IN GASTRIC CANCER TISSUE AND ADJACENT NORMAL TISSUE.
Zhou WP; Liu X; Yang Y; Liu YF
J Biol Regul Homeost Agents; 2015; 29(2):423-30. PubMed ID: 26122232
[TBL] [Abstract][Full Text] [Related]
11. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated gene silencing of NOB1 suppresses non-small cell lung cancer cell proliferation.
Huang W; Zhong W; Xu J; Su B; Huang G; Du J; Liu Q
Oncol Rep; 2015 Sep; 34(3):1510-6. PubMed ID: 26178254
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma.
Che JP; Li W; Yan Y; Liu M; Wang GC; Li QY; Yang B; Yao XD; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2300-11. PubMed ID: 24228091
[TBL] [Abstract][Full Text] [Related]
14. MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.
Luo L; Zhang T; Liu H; Lv T; Yuan D; Yao Y; Lv Y; Song Y
Med Oncol; 2012 Sep; 29(3):1681-6. PubMed ID: 21993632
[TBL] [Abstract][Full Text] [Related]
15. Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma.
Lin S; Meng W; Zhang W; Liu J; Wang P; Xue S; Chen G
J Int Med Res; 2013 Jun; 41(3):568-72. PubMed ID: 23685895
[TBL] [Abstract][Full Text] [Related]
16. Positive nin one binding protein expression predicts poor outcome in prostate cancer.
Chen J; Wang J; Cui X; Liu Y; Yin L; Li Y; Chen L; Xu D; Gao Y
Mol Med Rep; 2015 Apr; 11(4):2671-6. PubMed ID: 25503472
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Hrad17 gene in non-small cell lung cancers correlated with lymph node metastasis.
Sasaki H; Chen LB; Auclair D; Moriyama S; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Lung Cancer; 2001 Oct; 34(1):47-52. PubMed ID: 11557112
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma.
Li XY; Luo QF; Li J; Wei CK; Kong XJ; Zhang JF; Fang L
Int J Clin Exp Pathol; 2013; 6(10):2137-44. PubMed ID: 24133592
[TBL] [Abstract][Full Text] [Related]
19. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer.
Dong QZ; Zhao Y; Liu Y; Wang Y; Zhang PX; Jiang GY; Dong XJ; Cui QZ; Wang EH
Cancer Sci; 2010 Jun; 101(6):1562-9. PubMed ID: 20398053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]